A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy

In brief

A clinical study to measure the effect of OP-101 after being administered intravenously in healthy volunteers.

Key facts

Study ID

NCT03500627

Run by

Orpheris, Inc.

People needed

8

Starts

2018-03-30

Expected to finish

2018-07-20

Last updated by the study team

2018-09-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

Where it is running

• Medpace Clinical Pharmacology Unit — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.